QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Dogwood Therapeutics, Inc. (NASDAQ:DWTX) (the "Company"), a development-stage biotechnology company developing new medi...

Core News & Articles

HC Wainwright & Co. analyst Sean Lee maintains Dogwood Therapeutics (NASDAQ:DWTX) with a Buy and raises the price target...

Core News & Articles

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

Core News & Articles

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

Core News & Articles

LRMR: -53% | Larimar shares are trading lower after the company reported seven patients experienced anaphylaxis and were withdr...

Core News & Articles

Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(1.99) per share which missed the analyst consensus estimate o...

Core News & Articles

- Halneuron® Chemotherapy-Induced Neuropathic Pain ("CINP") Phase 2b study interim data readout remains on track as pro...

Core News & Articles

-SEC Filing

Core News & Articles

Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(8.45) per share which missed the analyst consensus estimate o...

Core News & Articles

HC Wainwright & Co. analyst Sean Lee upgrades Dogwood Therapeutics (NASDAQ:DWTX) from Neutral to Buy and announces $10 p...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION